Diaryl-Substituted Pyrazole Selective Cyclooxygenase-2 (COX-2) Inhibitor • Rx

Celecoxib

Brand Reference: Celebrex

Medically Reviewed by Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
87.10%
Patient “Worth It”
28 verified logs
$6.20
Lowest Monthly Cash

Celecoxib Clinical & Real-World Cost Fact Matrix

Metric Verified Benchmark Source
Celecoxib RxNorm Concept ID 140587 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.0680 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $49.00 / mo CMS NADAC + U.S. Retail Markup Index
Mark Cuban Cost Plus Wholesale Price $6.20 / mo Cost Plus Drugs Wholesale Feed
Community Mean Out-of-Pocket Paid $7.80 / mo 28 Zero-PHI Verified Patient Logs
INSTANT PRESCRIPTION & CASH ROUTING

Verified Online Prescribers & Wholesale Pharmacies for Celecoxib

DotMD Club Members get $29 flat-rate script renewals →
Mark Cuban Cost Plus Drugs (Wholesale Pharmacy)
Requires an existing doctor prescription. Need a script? Pair with a $29 DotMD Club TeleMed consult.
$6.20/mo
Wholesale Cash Price
View Wholesale Rx →
AgelessRx Geroprotective Telehealth (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~3 days • Rx included in monthly tier
$ 65.00
All-In Monthly
Start Online Visit →

Celecoxib Clinical Pharmacology & DailyMed Monograph

RxCUI 140587 • NDC 00378-5200-01

Inserts its sulfonamide side-pocket group into the larger hydrophobic channel of inducible inflammatory COX-2 (10-to-20-fold selectivity over gastric/platelet constitutive COX-1), suppressing prostaglandin E2 synovial inflammation while preserving gastric mucosal prostacyclin and TXA2 platelet aggregation.

Classified under Diaryl-Substituted Pyrazole Selective Cyclooxygenase-2 (COX-2) Inhibitor (Rx), Celecoxib exhibits a $42.80/month gap between standard U.S. retail cash counters ($49.00) and verified direct-to-patient routing ($6.20) anchored to $0.0680 CMS unit cost.

Pharmacokinetic profiling of Celecoxib demonstrates an elimination half-life of 11 hours with ~70% oral systemic bioavailability; clearance proceeds via hepatic cyp2c9 methyl-hydroxylation (halve dose in cyp2c9*3 poor metabolizers), reaching clinical onset within 60 minutes acute analgesia.

Titration schedules for Celecoxib (100 mg PO BID → 200 mg PO once daily) require excluding post-cabg surgery window; aspirin-exacerbated respiratory disease; sulfonamide anaphylaxis; real-world patient logs highlight dyspepsia (9% of reports), mild fluid retention (8% of reports) alongside a 87.10% Worth-It consensus.

Half-Life
11 hours
Bioavailability
~70% oral
Metabolism & Clearance
Hepatic CYP2C9 methyl-hydroxylation (halve dose in CYP2C9*3 poor metabolizers)
Clinical Onset
60 minutes acute analgesia

Standard Adult Titration & Dosages

100 mg PO BID 200 mg PO once daily

Absolute & Relative Contraindications

  • Post-CABG surgery window
  • Aspirin-exacerbated respiratory disease
  • Sulfonamide anaphylaxis

Logged Side-Effect Incidence (28 Reports)

Dyspepsia 9%
Mild fluid retention 8%

Celecoxib Patient Dosage Logs & Out-of-Pocket Cost Ledger

Across 28 verified cash-pay logs, Celecoxib achieves a 87.10% Worth-It rating with out-of-pocket spend averaging $7.80/mo versus $49.00/mo walk-in retail.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

Effectiveness: 5/5 • Worth It Dosage: 100 mg PO BID • Paid: $5.46/mo via Cost Plus Drugs
Dyspepsia

Switched to Cost Plus Drugs at 100 mg PO BID for Celecoxib; monthly out-of-pocket dropped to $5.46 compared with $49.00 retail.

Effectiveness: 5/5 • Worth It Dosage: 200 mg PO once daily • Paid: $6.32/mo via Cash Clinic

Completed 10 weeks on Celecoxib (200 mg PO once daily). Zero notable side effects on steady dosing.

Effectiveness: 4/5 • Worth It Dosage: 100 mg PO BID • Paid: $7.19/mo via Cost Plus Drugs
Dyspepsia

Consistent biomarker response on 100 mg PO BID Celecoxib sourced via Cost Plus Drugs ($7.19/mo cash pay without insurance prior authorization).